» Articles » PMID: 16568441

Behavioral and Educational Limitations After Chemotherapy for Childhood Acute Lymphoblastic Leukemia or Wilms Tumor

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2006 Mar 29
PMID 16568441
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The improved prognosis of childhood cancer makes monitoring of functional outcome important. The purpose of this study was to evaluate behavioral and educational functioning in survivors of childhood acute lymphoblastic leukemia (ALL) or a Wilms tumor. In this study, children with ALL received central nervous system directed chemotherapy without cranial irradiation.

Methods: In a multicenter study, behavioral functioning and school performance was examined in 199 children age 4 to 18. Sixty-four children were at least 1 year from finishing treatment with chemotherapy for ALL (n = 28) or a Wilms tumor (n = 36). They were compared with siblings (n = 37) and with a control group of healthy schoolchildren (n = 98).

Results: A moderately increased risk of behavioral and educational problems was found in children with ALL but not in children with Wilms tumor. School performance was poorer in children with ALL attending primary school compared with same-age peers; however, the rate of utilization of special education services was low. Teacher-rated behavior and mathematics performance was correlated with attention function in children with ALL. An excess of problem behavior and underperformance at school was found in the ALL high-risk group compared with the standard-risk group. No differences were found between siblings and controls.

Conclusion: Evidence is provided of subtle but significant behavioral and educational problems in survivors of childhood ALL, but no dysfunctions in survivors of a Wilms tumor. Careful follow-up of children with ALL treated with chemotherapy only is warranted.

Citing Articles

Back to School: Parental Concerns of Children with Hematological and Oncological Conditions During the COVID-19 Pandemic.

DiCola K, Antosy A, Steinberg D Contin Educ. 2024; 4(1):126-138.

PMID: 38774906 PMC: 11104308. DOI: 10.5334/cie.92.


Fatigue in children who have recently completed treatment for acute lymphoblastic leukemia: a longitudinal study.

Walsh S, Mulraney M, McCarthy M, De Luca C Health Qual Life Outcomes. 2024; 22(1):27.

PMID: 38519964 PMC: 10960388. DOI: 10.1186/s12955-024-02241-2.


Neurocognitive and psychosocial outcomes in survivors of childhood leukemia with Down syndrome.

Gandy K, Hall L, Krull K, Esbensen A, Rubnitz J, Jacola L Cancer Med. 2024; 13(3):e6842.

PMID: 38240104 PMC: 10905531. DOI: 10.1002/cam4.6842.


Impairments in fine motor skills in children with Acute Lymphoblastic Leukaemia. A cross-sectional study.

Tejeda-Castellanos X, Sanchez-Medina C, Marquez-Gonzalez H, Alaniz-Arcos J, Ortiz-Cornejo M, Brito-Suarez J BMC Pediatr. 2023; 23(1):513.

PMID: 37845644 PMC: 10578039. DOI: 10.1186/s12887-023-04316-3.


Educational outcomes in childhood cancer survivors: A Scotland-wide record-linkage study of 766,217 schoolchildren.

Baughan N, Pell J, Mackay D, Clark D, King A, Fleming M PLoS One. 2023; 18(7):e0286840.

PMID: 37494295 PMC: 10370705. DOI: 10.1371/journal.pone.0286840.